Get started

Cannabis

TLRY: Poor Q2 Earnings To Push Stock Back....For NowWhile many people have been super bullish on Tilray, I posted a little while ago my reasons why I am not bullish yet on the stock. I predicted their earnings would disappoint and they did. Tilray had a fake break-out to trick investors, and the stock increased to 46.00 and change today, only to give it all back post-earnings and back in its consolidation to 42.00 by the open tomorrow. While their revenues are increasing; their losses are mounting. However, after studying their balance sheet extensively, I believe most of their losses are due to business structural changes, rather than industry issues necessarily. I believe Tilray will break-out in-time for their Q1 2020 report. After their Q1 2020 report I believe we may finally see Tilray inching closer to the 60, 70 and 75.00 ranges. Moreover, I believe the poor earnings may push the stock below 40.00 temporarily (not for too long), and that should be your buy zone. I do not recommend buying the stock now because you won't get any decent ROE for a while. Ideally, you want to set a stop loss buy for about 35.39 and closely monitor the stock to see if you can get such an entry. If you are desperate to own the stock then anything at 39.00 or below is recommended. - zSplit
NASDAQ:TLRY
by PaulDeep19131
At Key Resistance After Small Run-up On Product AnticipationBroke a long, deep 6 month downtrend last week. With the announcement of their product stocking shelves on 8/06/19, I can see this cutting through .15 (key resistance) and head up to the.175 level short term. Volume is building, however today's spinning top ( which I believe it is) on the daily may sell us down slightly before legging up IMO. Plan... trading levels to Fibs and SMA... 200 day MA &.178... Average cost .143. Sell half of position @ .17... Stop .115...
OTC:GBLXLong
by BULL420
Can Tilray Get Back to over $100?Looking at Tilray with the MACD and Megalodon indicators, we can see a buy signal on the daily for Tilray. Something that we've seen only twice before, both times being the start of significant rise. The Daily MACD doesn't have as much room to turn as did previous signals, however it does look a lot sturdier and supportive. As of right now though, we cannot chase this stock. Looking at the shorter time frame we can see a strong sell signal from the Megalodon. So while I am feeling confident about Tilray in the long term, we must wait for a short term correction to find our buying opportunity. The Megalodon indicator uses a machine learning algorithm, combined with data from over 500 buy setups, and over 2000 indicators to produce extremely accurate buy signals on any and all asset classes! You will also receive real time buy and sell signals for the stock market, cryptocurrency, as well as forex markets! We also busy completed our cryptocurrency automated trade bot. It trades for you, using our backtested indicator with phenomenal results! So try it today!!!
NASDAQ:TLRYLong
by RandallGurule
1
EnWave: Buy the Lows and Go Long!EnWave will likely be one of the key hidden gems in the biotechnological industry and will continue to gain volume as time progresses. Their company focuses on a multitude of revenue streams for dehydration techniques (patented) and has several revenue streams including royalty bearing and selling their equipment to other companies. This is one of the most stable dollar stocks on the market right now as a result of their market cap to stock value ratio, as well as, given their stock price, they are actually on the verge of profitability before 2020. As time progresses they continue to sign deals with international companies around the world and the stock value will only continue to grow. They focus strongly in (but not exclusively with) the cannabis dehydration market; while cannabis has been hit brutally hard from CannTrust's scandal recently, I am eyeing a rebound beginning September for the cannabis industry, and even though EnWave continued to increase during the downturn, I am looking at a breakout in Q4 2019 to 3.50-4.00. Just like the semis got demolished and made a roaring rebound, I expect the same in Q4 of 2019 of cannabis and will likely be a leading sector, although most stocks likely won't make any new highs. Remember: Dollar stocks never move linearly and always have several retracements. Never buy dollar stocks all at once - never sell them all at once, even when breakouts occur. However, go long in EnWave! - zSplit
TSXV:ENWLong
by PaulDeep19131
GROW Double BottomDowntrend over last few weeks may be over as todays bullish engulfing shows signs of reversal. Watch for break of 0.35 to confirm bull break from falling wedge. Close above 0.35 would also be a hammer on the weekly chart. Good buy right now with strong support at 0.30, price target at recent tops of 0.51, potentially higher with any good news releases. Upcoming catalysts include new contract signings, approval for use of technology on cannabis and more agro-industrial partnerships.
TSXV:GROWLong
by Unlikely-Bite
1
Wait!I am not betting for this stock to drop nor in favor of it going up. With the MACD appeared to be seemingly showing signs that it wants to go Bull. It is not good enough. The news might be saying good stuff about CRONOs, but the Canadian cannabis market is a disaster. With the stock trading between the range and close to earnings report. Unless the earnings report is super positive, I don't see any reason for this stock to raise. Only chance for a buy in my opinion: 1/ MACD showing clear signs of bullish momentum. 2/ Positive earnings report. 3/ Breakout of resistance level. Until then, keep waiting. :P
TSX:CRON
by TradingCow
Acreage Holdings - Insider Open-Market Stock PurchaseJuly 15, 2019 (GLOBE NEWSWIRE) -- Acreage Holdings, Inc. (“Acreage”) (OTCQX: ACRGF) today announced Kevin Murphy, Chairman, and Chief Executive Officer of Acreage Holdings, executed an open market stock purchase for 154,000 shares through the OTCQX on July 12th. The transaction, valued at more than US $2,000,000, was executed on the OTCQX open market on Friday, July 12th. The 154,000 shares acquired represented more than 72% of the average daily trading volume on the OTCQX. “With the downturn in industry stock prices recently, this was an opportunity to show investors that Acreage management is committed to creating long-term shareholder value,” said Murphy. “We remain focused on executing on our strategic plans, including fully leveraging the power of Canopy’s IP. Additionally, we have been in dialogue with executives from both Canopy and Constellation, and I can assure all of our investors that all three companies remain fully committed and excited about our recently executed agreement.”
ALong
by dorfmanmaster
Cannabis headlines - turning bullishThe Cannabis ETF (MJ -4%) is trading at at six-month low as investor hype around cannabis stocks has faded. In a somewhat predictable sell-the-news reaction, the MJ ETF peaked when recreational cannabis went into effect last Fall after staging a massive run leading up to the highly anticipated event. Since then, the onus has been on companies to deliver. Most of them have begun reporting enviably strong sales growth, but the euphoric valuations had priced in a generous amount of future success. Last week, Canopy Growth (CGC) Founder Bruce Linton was ousted from his role as co-CEO. He did a great job scaling the largest cannabis company in the world, but Constellation Brands (STZ) sought a more sound operational manger for the next phase of growth at its multi-billion dollar cannabis investment. This week, CannTrust (CTST) announced that it was non-compliant with certain regulations in Canada, resulting in millions of grams of inventory being put on hold. The stock has nearly been cut in half. The cannabis market is still nascent and the THC and CBD markets have tremendous long-term potential, but unforeseen events are par for the course in the world of business. In hindsight, cannabis stocks were priced for perfection, so it was just a matter of time before sentiment cooled off. Cannabis stocks have pulled back from their aggressive valuations as expectations have been set at a more reasonable level. Headwinds in the form of regulations and capacity constraints appear to be abating as the industry starts to mature. The growth outlook remains very promising. Despite the recent sell off, the leading (largest) cannabis companies Canopy Growth (CGC), Tilray (TLRY) and Aurora (ACB) still trade at ~20x forward revenue estimates. With the backing of Altria (MO), Cronos (CRON) is even more expensive relative to sales estimates while Aphria (APHA) trades at a discount. --- Briefing . com
AMEX:MJLong
by dorfmanmaster
1
Breaking SupportHEXO had taken a huge beating for the last 2 months. It was projected to hit $12 this year, turned out the government messed up so badly that the stock plummeted. HEXO found support at $6.60 range. Today heard more news about pricing issue that black market cannabis is still much cheaper than retail... (as it should) I can expect this stock to breakthrough support and continue on the downtrend. However IIPR is still going strong forming consolidation. If you are a long person. Check that out.
TSX:TLRYShort
by TradingCow